Literature DB >> 22019819

Successful treatment with echinocandin in an HIV-infected individual failing first-line therapy for Pneumocystis jirovecii pneumonia.

M Elena Ceballos, Marcos Ortega, Max Andresen, Aniela Wozniak, Patricia García, M Elvira Balcells.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22019819     DOI： 10.1097/QAD.0b013e32834c4c3c

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  4 in total

1.  Fatal Pneumocystis jirovecii pneumonia in a HIV-negative adult.

Authors:  Toufik Mahfood Haddad; Saraschandra Vallabhajosyula; Muhammad Sarfraz Nawaz; Renuga Vivekanandan
Journal:  BMJ Case Rep       Date:  2015-08-26

2.  Site-Directed Mutagenesis of the 1,3-β-Glucan Synthase Catalytic Subunit of Pneumocystis jirovecii and Susceptibility Assays Suggest Its Sensitivity to Caspofungin.

Authors:  A Luraschi; S Richard; P M Hauser
Journal:  Antimicrob Agents Chemother       Date:  2018-11-26       Impact factor: 5.191

3.  Efficacy of caspofungin combined with clindamycin for Pneumocystis jirovecii pneumonia in a systemic lupus erythematosus patient: A case report and literature review.

Authors:  Di-Hong Yang; Yuan Xu; Lu Hong; Zhou-Ye Song; Wei-Hong Ge
Journal:  Respir Med Case Rep       Date:  2018-12-08

4.  Caspofungin combined with TMP/SMZ as a first-line therapy for moderate-to-severe PCP in patients with human immunodeficiency virus infection.

Authors:  Q Tian; J Si; F Jiang; R Xu; B Wei; B Huang; Q Li; Z Jiang; T Zhao
Journal:  HIV Med       Date:  2020-12-04       Impact factor: 3.180
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.